Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (528) 528
science & technology (479) 479
life sciences & biomedicine (448) 448
phenylbutyrates - therapeutic use (365) 365
male (340) 340
animals (290) 290
phenylbutyrates - pharmacology (287) 287
female (243) 243
biological and medical sciences (161) 161
adult (160) 160
medical sciences (155) 155
middle aged (154) 154
mice (126) 126
aged (108) 108
pharmacology & pharmacy (92) 92
pharmacology. drug treatments (88) 88
oncology (84) 84
phenylbutyrates (82) 82
rats (80) 80
isoindoles (74) 74
apoptosis (72) 72
endoplasmic reticulum stress - drug effects (72) 72
phenylbutyrates - adverse effects (72) 72
phenylbutyrates - administration & dosage (69) 69
proteins (64) 64
apoptosis - drug effects (63) 63
phenylbutyric acid (61) 61
phenylbutyrate (60) 60
abridged index medicus (57) 57
endoplasmic reticulum stress (57) 57
endoplasmic reticulum (55) 55
anti-inflammatory agents - therapeutic use (53) 53
antineoplastic agents - pharmacology (53) 53
antineoplastic agents - therapeutic use (53) 53
adolescent (52) 52
analysis (52) 52
cell biology (52) 52
medicine, research & experimental (52) 52
platelet aggregation inhibitors - therapeutic use (52) 52
research (52) 52
research & experimental medicine (52) 52
cell line, tumor (51) 51
child (51) 51
dose-response relationship, drug (51) 51
biochemistry & molecular biology (48) 48
clinical trials as topic (48) 48
disease models, animal (46) 46
time factors (45) 45
neurosciences & neurology (44) 44
cells, cultured (43) 43
double-blind method (43) 43
mice, inbred c57bl (42) 42
mutation (41) 41
antineoplastic agents (40) 40
genetics & heredity (40) 40
histone deacetylase inhibitors (39) 39
propionates - therapeutic use (39) 39
treatment outcome (39) 39
health aspects (38) 38
rodents (38) 38
child, preschool (37) 37
gene expression (36) 36
protein folding (36) 36
care and treatment (35) 35
chemotherapy (35) 35
neurosciences (35) 35
histone deacetylase inhibitors - pharmacology (34) 34
signal transduction - drug effects (34) 34
cell line (33) 33
endocrinology & metabolism (33) 33
phenylbutyrates - chemistry (33) 33
rats, sprague-dawley (33) 33
research article (32) 32
urea (32) 32
physiological aspects (31) 31
biphenyl compounds (30) 30
medicine (30) 30
science & technology - other topics (30) 30
tumors (30) 30
aspirin - therapeutic use (29) 29
cancer (29) 29
medicine & public health (29) 29
multidisciplinary sciences (29) 29
sodium phenylbutyrate (29) 29
stress (29) 29
gastroenterology & hepatology (28) 28
neurology (28) 28
blotting, western (27) 27
endoplasmic reticulum - drug effects (27) 27
liver (27) 27
phenylbutyrates - pharmacokinetics (27) 27
administration, oral (26) 26
arthritis, rheumatoid - drug therapy (26) 26
drug therapy (26) 26
drug therapy, combination (26) 26
endoplasmic reticulum - metabolism (25) 25
histone deacetylase (25) 25
neoplasms - drug therapy (25) 25
pediatrics (25) 25
ammonia (24) 24
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (661) 661
Italian (23) 23
French (20) 20
Japanese (12) 12
Russian (12) 12
German (8) 8
Polish (5) 5
Chinese (4) 4
Czech (2) 2
Swedish (2) 2
Danish (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Serbian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Hepatic encephalopathy due to liver cirrhosis
by Ellul, Mark A and Gholkar, Santosh A and Cross, Timothy J
BMJ : British Medical Journal, ISSN 0959-8138, 8/2015, Volume 351, pp. h4187 - h4187
CLINICAL REVIEW | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Phenylbutyrates - therapeutic use | Humans | Ornithine - analogs & derivatives | Ornithine - therapeutic use | Tomography, X-Ray Computed | Electroencephalography | Albumins - therapeutic use | Rifamycins - therapeutic use | Hepatic Encephalopathy - diagnosis | Hepatic Encephalopathy - etiology | Disaccharides - therapeutic use | Glycerol - analogs & derivatives | Drug Resistance | Terminal Care - methods | Glycerol - therapeutic use | Nucleic Acid Synthesis Inhibitors - therapeutic use | Diagnosis, Differential | Liver Cirrhosis - complications | Neomycin - therapeutic use | Amino Acids - therapeutic use | Magnetic Resonance Imaging | Hepatic Encephalopathy - therapy | Neurologic Examination | Diet | Probiotics - therapeutic use | Protein Synthesis Inhibitors - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis
by Zacharias, Harry D and Zacharias, Antony P and Gluud, Lise Lotte and Morgan, Marsha Y and Morgan, Marsha Y
Cochrane library, ISSN 1469-493X, 01/2019, Volume 2019, Issue 7, pp. CD012334 - CD012334
Medical interventions | Phenylbutyrates | Polyethylene Glycols | Lactulose | Gastroenterology & hepatology | Hepatic Encephalopathy | Liver disorders | Glycerol | Oxides | Liver Cirrhosis | Ammonia scavenging agents | Sodium Benzoate | Carbon | Cause of Death | Randomized Controlled Trials as Topic | HEPATIC ENCEPHALOPATHY (K72.9) | Ammonia | Treatment | Liver disease (general treatments) | Placebos | Ornithine | Medicine General & Introductory Medical Sciences | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Phenylbutyrates - therapeutic use | Humans | Middle Aged | Phenylbutyrates - adverse effects | Ornithine - analogs & derivatives | Polyethylene Glycols - adverse effects | Male | Ornithine - therapeutic use | Hepatic Encephalopathy - drug therapy | Polyethylene Glycols - therapeutic use | Ornithine - adverse effects | Placebos - therapeutic use | Adult | Female | Lactulose - therapeutic use | Glycerol - analogs & derivatives | Glycerol - therapeutic use | Oxides - therapeutic use | Carbon - therapeutic use | Glycerol - adverse effects | Liver Cirrhosis - complications | Ammonia - antagonists & inhibitors | Hepatic Encephalopathy - prevention & control | Sodium Benzoate - therapeutic use | Sodium Benzoate - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Drug treatment for spinal muscular atrophy types II and III
by Wadman, Renske I and Bosboom, Wendy M. J and van der Pol, W. Ludo and van den Berg, Leonard H and Wokke, John H. J and Iannaccone, Susan T and Vrancken, Alexander F. J. E
Cochrane database of systematic reviews, ISSN 1469-493X, 01/2012, Issue 4, pp. CD006282 - CD006282
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neuroprotective Agents - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Phenylbutyrates - therapeutic use | Gabapentin | Humans | Child, Preschool | Spinal Muscular Atrophies of Childhood - drug therapy | Disease Progression | Randomized Controlled Trials as Topic | Adolescent | Amines - therapeutic use | Thyrotropin-Releasing Hormone - therapeutic use | Creatine - therapeutic use | Hydroxyurea - therapeutic use | Valproic Acid - therapeutic use | gamma-Aminobutyric Acid - therapeutic use | Acetylcarnitine - therapeutic use | Child | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Drug treatment for spinal muscular atrophy types II and III
by Wadman, Renske I and Wadman, Renske I and Bosboom, Wendy M J and Bosboom, Wendy Mj and van der Pol, W Ludo and van den Berg, Leonard H and van den Berg, Leonard H and Wokke, John Hj and Wokke, John H J and Iannaccone, Susan T and Vrancken, Alexander Fje and Iannaccone, Susan T and Vrancken, Alexander F J E
Cochrane database of systematic reviews, ISSN 1469-493X, 2012, Volume 4, Issue 12, pp. CD006282 - CD006282
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neuroprotective Agents - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Phenylbutyrates - therapeutic use | Gabapentin | Humans | Child, Preschool | Spinal Muscular Atrophies of Childhood - drug therapy | Randomized Controlled Trials as Topic | Adolescent | Amines - therapeutic use | Thyrotropin-Releasing Hormone - therapeutic use | Creatine - therapeutic use | Hydroxyurea - therapeutic use | Valproic Acid - therapeutic use | gamma-Aminobutyric Acid - therapeutic use | Acetylcarnitine - therapeutic use | Child | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text The therapeutic effects of 4-phenylbutyric acid in maintaining proteostasis
by Kolb, P.S and Ayaub, E.A and Zhou, W and Yum, V and Dickhout, J.G and Ask, K
The international journal of biochemistry & cell biology, ISSN 1357-2725, 04/2015, Volume 61, pp. 45 - 52
4-Phenylbutyric acid | ER stress | 4-PBA | UPR | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Unfolded Protein Response - drug effects | Phenylbutyrates - therapeutic use | Animals | Endoplasmic Reticulum Stress - drug effects | Signal Transduction | Endoplasmic Reticulum - drug effects | Humans | Endoplasmic Reticulum - metabolism | Homeostasis | Phenylbutyrates - pharmacology | Urea Cycle Disorders, Inborn - drug therapy | Proteins | Urea | Health aspects | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Peptidomimetic inhibitors of HIV protease
by Randolph, John T and DeGoey, David A
Current topics in medicinal chemistry, ISSN 1568-0266, 2004, Volume 4, Issue 10, pp. 1079 - 1095
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Anti-HIV Agents - pharmacology | Pyridines - chemistry | Humans | Saquinavir - therapeutic use | Urethane - chemistry | Pyrimidinones - chemistry | Oligopeptides - therapeutic use | HIV Protease Inhibitors - pharmacology | Saquinavir - pharmacology | Urethane - therapeutic use | Atazanavir Sulfate | Phenylbutyrates - pharmacology | Ritonavir - therapeutic use | Oligopeptides - chemistry | Saquinavir - chemistry | Lopinavir | Pyrimidinones - therapeutic use | Models, Molecular | Sulfonamides - pharmacology | HIV Protease Inhibitors - therapeutic use | Nelfinavir - pharmacology | Anti-HIV Agents - chemistry | Carbamates | Urethane - pharmacology | Oligopeptides - pharmacology | Organophosphates - therapeutic use | Indinavir - pharmacology | Urethane - analogs & derivatives | HIV - drug effects | Molecular Mimicry | Phenylbutyrates - chemistry | Anti-HIV Agents - therapeutic use | Pyrimidinones - pharmacology | Ritonavir - pharmacology | Molecular Structure | Pyridines - therapeutic use | Nelfinavir - therapeutic use | Peptides - chemistry | Sulfonamides - chemistry | Dipeptides - pharmacology | HIV Protease Inhibitors - chemistry | Clinical Trials as Topic | Dipeptides - chemistry | Ritonavir - chemistry | Peptides - pharmacology | Organophosphates - pharmacology | Sulfonamides - therapeutic use | HIV Infections - drug therapy | Organophosphates - chemistry | Pyridines - pharmacology | Peptides - therapeutic use | Indinavir - therapeutic use | Index Medicus
Journal Article
Details down arrow